-
Application for production of bortezomib for injection of six chemical drugs in Haizheng Pharmaceutical Co., Ltd. was accepted
Time of Update: 2020-04-03
Bortezomib for injection, a 6-class chemical drug declared by Haizheng pharmaceutical, has been accepted According to the inquiry, the company has previously applied for bortezomib as the drug substan
-
Application of Tangning Tongluo capsule, a new diabetes drug of Guizhou bailing, to medical institutions
Time of Update: 2020-04-03
August 24, bailing, Guizhou According to the investor interaction platform, Tangning Tongluo capsule, the company's new diabetes drug, is currently applying for the preparation of medical institutions
-
Three new indications of pegylated recombinant human growth hormone injection in Jinsai pharmaceutical were approved
Time of Update: 2020-04-03
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without any false record, misleading statement or major omission T
-
Zhifei biological heavyweight AC Hib vaccine is on the market after GMP certification
Time of Update: 2020-04-03
According to the information on CFDA website, the production workshops of two vaccine products, AC group meningococcal (combined) Haemophilus influenzae (combined) combined vaccine (hereinafter referr
-
Temozolomide, a class 3.3 new antitumor drug of Hengrui medicine, has obtained clinical approval
Time of Update: 2020-04-03
Temozolomide for injection of Hengrui medicine has completed the clinical examination and approval, and is in the state of pending certification It is worth noting that the temozolomide for injection
-
Kangyuan pharmaceutical won the national science and technology progress award again
Time of Update: 2020-04-03
On January 8, good news came from the 2015 National Science and technology award conference: Kangyuan Pharmaceutical Co., Ltd led to complete the project of "establishment and application of quality s
-
Tonghua Dongbao's first three generations of insulin glargine obtained clinical approval
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 9, the current status of the third generation insulin glargine bulk drug and preparation glargine insulin injection de
-
Patent of recombinant human interferon β - 1A of Haizheng pharmaceutical industry was approved
Time of Update: 2020-04-03
The purification method of recombinant human interferon β - 1A declared by Haizheng pharmaceutical recently has obtained the invention patent certificate of the State Intellectual Property Office It i
-
Application for patent of Tangning Tongluo capsule, a new drug of Guizhou bailing, was accepted
Time of Update: 2020-04-03
However, Guizhou bailing also reminded that the development of Tangning Tongluo Capsule project has a long cycle and large investment, and there are risks and major uncertainties in each stage The rep
-
China's new drugs go to the United States!
Time of Update: 2020-04-03
The significance of the release of risperidone microsphere injection (ly03004) is that it is expected to become the first Chinese new drug approved and listed in the United States, and will represent
-
Changshan pharmaceutical sodium hyaluronate has completed clinical trials
Time of Update: 2020-04-03
Zhang Wei, financial director and Secretary of Changshan pharmaceutical industry, said in a conference call that at present, the main construction of the company's sodium hyaluronate new car room has
-
Changshan pharmaceutical is expected to obtain the production approval this month
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on May 6, the declaration and production status of the first heavy generic drug of Changshan Pharmaceutical Co., Ltd for hepar
-
3.1 the first batch of imitations of levetiracetam are coming out
Time of Update: 2020-04-03
According to the information on May 14 on the website of the State Food and Drug Administration (CFDA), zuoxiracetam APIs and tablets, a class 3.1 chemical drug, which are applied for production by xi
-
Changchun high tech live attenuated herpes zoster vaccine is expected to obtain clinical approval this year
Time of Update: 2020-04-03
Yang Zhanmin, chairman of Changchun hi tech, said at the 2013 performance presentation meeting that the new drug "live attenuated herpes zoster vaccine" that the company is applying for clinical appli
-
Nanjing jianyouda heparin sodium injection and low molecular weight heparin calcium injection were inspected on site this month
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 17, the daparin sodium injection and low molecular weight heparin calcium injection declared by Nanjing Jianyou for pr
-
Application for clinical application of class 3.1 new anti infective drug of Haizheng pharmaceutical
Time of Update: 2020-04-03
According to the information released by the State Food and Drug Administration on July 29, Haizheng Pharmaceutical Co., Ltd applied for the clinical application of 3.1 new anti infective drug, fidamy
-
The production of "loratrak hydrochloride", a new anti-tumor drug of Kangchen Pharmaceutical Co., Ltd., has been declared
Time of Update: 2020-04-03
Loratrek hydrochloride for injection, a national first-class anti-cancer drug developed by Kangchen Pharmaceutical Development Co., Ltd., is a non classical structure of folic acid thymidylate synthet
-
The first phase of "recombinant human tumor necrosis factor related apoptosis inducing ligand for injection" was completed
Time of Update: 2020-04-03
On March 24, humanwell said at the 2013 performance presentation meeting that the first class new drug "recombinant human tumor necrosis factor related apoptosis inducing ligand for injection" of Shen
-
Roche's Chugai non-small cell lung cancer targeting drug alectinib approved by Japan
Time of Update: 2020-04-03
Alectinib, the latest targeted drug for anaplastic lymphoma kinase (ALK) - positive non-small cell lung cancer, has been approved for the first time in Japan The anti-tumor drug will be introduced to
-
Chuanshegan flavone capsule, a new Chinese medicine of Fengchun pharmaceutical, has obtained the production approval and new drug certificate
Time of Update: 2020-04-03
Recently, Sichuan Fengchun Pharmaceutical Co., Ltd applied for chuanshegan flavone capsule, a new Chinese medicine, which has been approved for production and marketing after Sichuan Kangding Jinzhu P
